BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 7764038)

  • 1. Uses of beta-galactosidase tag in on-line monitoring production of fusion proteins and gene expression in Escherichia coli.
    Benito A; Valero F; Lafuente J; Vidal M; Cairo J; Solà C; Villaverde A
    Enzyme Microb Technol; 1993 Jan; 15(1):66-71. PubMed ID: 7764038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The position of the heterologous domain can influence the solubility and proteolysis of beta-galactosidase fusion proteins in E. coli.
    Corchero JL; Viaplana E; Benito A; Villaverde A
    J Biotechnol; 1996 Jul; 48(3):191-200. PubMed ID: 8861998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasmid maintenance in Escherichia coli recombinant cultures is dramatically, steadily, and specifically influenced by features of the encoded proteins.
    Corchero JL; Villaverde A
    Biotechnol Bioeng; 1998 Jun; 58(6):625-32. PubMed ID: 10099300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis in Escherichia coli of the major glycoprotein of human rotavirus: analysis of the antigenic regions.
    Johnson MA; Misra RM; Lardelli M; Messina M; Ephraums C; Reeves PR; Bolcevic Z; Noel JS; Hum CP; Van Mai H
    Gene; 1989 Dec; 84(1):73-81. PubMed ID: 2481606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of fusion proteins with multiple copies of an antigenic determinant of foot-and-mouth disease virus.
    Broekhuijsen MP; Blom T; van Rijn J; Pouwels PH; Klasen EA; Fasbender MJ; Enger-Valk BE
    Gene; 1986; 49(2):189-97. PubMed ID: 2436976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficient use of lactose for the lac promoter-controlled overexpression of the main antigenic protein of the foot and mouth disease virus in Escherichia coli under fed-batch fermentation conditions.
    Neubauer P; Hofmann K
    FEMS Microbiol Rev; 1994 May; 14(1):99-102. PubMed ID: 8011364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression in Escherichia coli of the major outer capsid protein of infectious pancreatic necrosis virus.
    Lawrence WR; Nagy E; Duncan R; Krell P; Dobos P
    Gene; 1989 Jul; 79(2):369-74. PubMed ID: 2507397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of the outer-capsid glycoprotein of the simian rotavirus SA11 in Escherichia coli.
    Arias CF; Ballado T; Plebañski M
    Gene; 1986; 47(2-3):211-9. PubMed ID: 3030891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of the N-terminal hydrophobic sequence of hepatitis B virus surface antigen on the folding and assembly of hybrid beta-galactosidase in Escherichia coli.
    Lee SC; Choi YC; Yu MH
    Eur J Biochem; 1990 Jan; 187(2):417-24. PubMed ID: 2105218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purification of fusion proteins expressed by pEX3 and a truncated pEX3 derivative.
    Kocken CH; Scheer JM; Welling GW; Welling-Wester S
    FEBS Lett; 1988 Aug; 236(1):132-4. PubMed ID: 3136038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of heterologous proteins in Saccharomyces cerevisiae using the ADH2 promoter.
    Price VL; Taylor WE; Clevenger W; Worthington M; Young ET
    Methods Enzymol; 1990; 185():308-18. PubMed ID: 2116576
    [No Abstract]   [Full Text] [Related]  

  • 12. Insertion of a 27 amino acid viral peptide in different zones of Escherichia coli beta-galactosidase: effects on the enzyme activity.
    Benito A; Villaverde A
    FEMS Microbiol Lett; 1994 Oct; 123(1-2):107-12. PubMed ID: 7988875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of a global deregulation of the heat-shock response on the expression of heterologous proteins in Escherichia coli.
    Thomas JG; Baneyx F
    Ann N Y Acad Sci; 1996 May; 782():478-85. PubMed ID: 8659918
    [No Abstract]   [Full Text] [Related]  

  • 14. Cultivation of recombinant E. coli and production of fusion protein in 60-1 bubble column and airlift tower loop reactors.
    Kracke-Helm HA; Rinas U; Hitzmann B; Schügerl K
    Enzyme Microb Technol; 1991 Jul; 13(7):554-64. PubMed ID: 1367639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of an antigenic polypeptide of the human parvovirus B19.
    Eiffert H; Köchel HG; Heuer M; Tratschin JD; Thomssen R
    Med Microbiol Immunol; 1990; 179(4):169-75. PubMed ID: 2175835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production of recombinant baculoviruses using rapid screening vectors that contain the gene for beta-galactosidase.
    Lalumière M; Richardson CD
    Methods Mol Biol; 1995; 39():161-77. PubMed ID: 7620548
    [No Abstract]   [Full Text] [Related]  

  • 17. Enhanced production of pL-controlled recombinant proteins and plasmid stability in Escherichia coli RecA+ strains.
    Benito A; Vidal M; Villaverde A
    J Biotechnol; 1993 Jun; 29(3):299-306. PubMed ID: 7764065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of fusion proteins containing antigenic determinants of foot-and-mouth disease virus.
    Broekhuijsen MP; Blom T; Kottenhagen M; Pouwels PH; Meloen RH; Barteling SJ; Enger-Valk BE
    Vaccine; 1986 Jun; 4(2):119-24. PubMed ID: 2425505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Construction and properties of bifunctionally active membrane-bound fusion proteins. Escherichia coli proline carrier linked with beta-galactosidase.
    Hanada K; Yamato I; Anraku Y
    J Biol Chem; 1987 Oct; 262(29):14100-4. PubMed ID: 3115984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamics of in vivo protein aggregation: building inclusion bodies in recombinant bacteria.
    Carrió MM; Corchero JL; Villaverde A
    FEMS Microbiol Lett; 1998 Dec; 169(1):9-15. PubMed ID: 9851031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.